Chemoinformaics analysis of Benzyl-2,3,5,6-tetramethoxybenzoate
| Molecular Weight | 332.352 | nRot | 7 |
| Heavy Atom Molecular Weight | 312.192 | nRig | 13 |
| Exact Molecular Weight | 332.126 | nRing | 2 |
| Solubility: LogS | -3.657 | nHRing | 0 |
| Solubility: LogP | 2.758 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 12 |
| nHA | 6 | APOL | 48.2079 |
| nHD | 0 | BPOL | 29.6121 |
| QED | 0.726 |
| Synth | 1.903 |
| Natural Product Likeliness | -0.049 |
| NR-PPAR-gamma | 0.009 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.968 |
| Pgp-sub | 0 |
| HIA | 0.004 |
| CACO-2 | -4.688 |
| MDCK | 0.000033 |
| BBB | 0.501 |
| PPB | 0.847062 |
| VDSS | 0.66 |
| FU | 0.0673577 |
| CYP1A2-inh | 0.769 |
| CYP1A2-sub | 0.938 |
| CYP2c19-inh | 0.936 |
| CYP2c19-sub | 0.875 |
| CYP2c9-inh | 0.738 |
| CYP2c9-sub | 0.861 |
| CYP2d6-inh | 0.132 |
| CYP2d6-sub | 0.879 |
| CYP3a4-inh | 0.762 |
| CYP3a4-sub | 0.818 |
| CL | 7.944 |
| T12 | 0.71 |
| hERG | 0.296 |
| Ames | 0.066 |
| ROA | 0.013 |
| SkinSen | 0.607 |
| Carcinogencity | 0.096 |
| EI | 0.65 |
| Respiratory | 0.038 |
| NR-Aromatase | 0.363 |
| Antiviral | Yes |
| Prediction | 0.82246 |